Ann: Acquisition of Biogenic Methane Enhancement , page-2

re: Ann: RER: Acquisition of Biogenic Methane... So this should boost their otherwise scantly dressed balance sheet. $200k plus another potential $200k or more in RER holdings. I took a position last week on the simplicity it looks supported by 35million at .003c. IMO looks as if they are tightening up positively as a company.

Transol will receive $200,000 in funds that have previously been loaned to EBM to fund that companys activities, and will have no ongoing obligation to provide more loan funds. Transol will be issued 20 million fully paid shares in Regal and will retain a 2.5% royalty on well head production from commercial quantities of methane produced from the use of EBM technology within Australia and Northern Ireland. The royalty agreement and shareholding in Regal will enable Transol shareholders to benefit from a direct shareholding in Regal and from royalty payments should the EBM technology have commercial applications. Completion of the sale is subject to Regal shareholders approving the issue of the 20 million shares at Regals forthcoming annual general
meeting.